
Santhosh Kukkadi Sadashiv MD
Hematologic Oncology
Associate Program Director Division of Hematology and Cellular Therapy
Join to view full profile
4815 Liberty AveSte 322Pittsburgh, PA 15224
Phone+1 412-578-4484
Fax+1 412-578-3536
Dr. Sadashiv is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2011 - 2014
UMass Chan - BaystateFellowship, Geriatric Medicine (Internal Medicine), 2003 - 2004
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2000 - 2003
Siddhartha Medical College NTRClass of 1998
Certifications & Licensure
PA State Medical License 2003 - 2026
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- Two Decades of Light-Chain Amyloidosis: Real-World Trends in Diagnosis, Treatment, and Survival.Grace Gorecki, Oyepeju Abioye, Jivtesh Singh, Maahin Parvez, Santoshini Adivi
Journal of Hematology. 2026-06-01 - Light Chain (AL) Amyloidosis Masquerading as Scleroderma: A Diagnostic Challenge.Kriti Dhamija, Rahim A Jiwani, Arjun Lakshaman, Santhosh Sadashiv, Prerna Mewawalla
Journal of Hematology. 2025-06-01 - Delayed Diagnosis of Poems Syndrome, How AI Tools Can Enhance Diagnostic Accuracy.Max Jin, Sowbharnika Arivazhagan, Prerna Mewawalla, Santhosh Sadashiv, Arjun Lakshman
European Journal of Case Reports in Internal Medicine. 2025-01-01
Journal Articles
- Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.Santhosh K Sadashiv, Christie Hilton, Cyrus Khan, James M Rossetti, Heather L Benjamin, Salman Fazal, Entezam Sahovic, Richard K Shadduck, and John Lister, Cancer Med. 2014 Dec; 3(6): 1570–1578., 8/16/2014
- Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.Santhosh K Sadashiv, Christie Hilton, Cyrus Khan, James M Rossetti, Heather L Benjamin, Salman Fazal, Entezam Sahovic, Richard K Shadduck, and John Lister, Cancer Med. 2014 Dec; 3(6): 1570–1578., 8/16/2014
- Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.Santhosh K Sadashiv, Christie Hilton, Cyrus Khan, James M Rossetti, Heather L Benjamin, Salman Fazal, Entezam Sahovic, Richard K Shadduck, and John Lister, Cancer Med. 2014 Dec; 3(6): 1570–1578., 8/16/2014
Abstracts/Posters
- Autologous Stem Cell Transplantation in Multiple Myeloma Patients Older Than 65 Year-Old, 12-Years Analysis of National Cancer DatabaseSanthosh Sadashiv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Impact of Socioeconomic Factors on Timeliness of First Line Chemotherapy and Survival in Patients with Active Multiple MyelomaSanthosh Sadashiv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- In-Hospital Complications and Outcomes of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Older Than 65-Years Old in the United States: National Inpa...Santhosh Sadashiv, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
VTE Risk and Incidence in Hospitalized Patients with Blood CancersOctober 25th, 2019
Doctors Making Progress in Treating AmyloidosisMarch 7th, 2019
Pittsburgh-Area Businessmen, Friends Diagnosed with Rare Blood Cancer 4 Months ApartJuly 12th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









